PATHWAYS clinical trial paused following new MHRA advice
The MHRA have raised new concerns around the PATHWAYS trial looking into the prescription of puberty blockers among young people with gender incongruence.
Read moreThe MHRA have raised new concerns around the PATHWAYS trial looking into the prescription of puberty blockers among young people with gender incongruence.
Read morePatients across the country will have better access to NHS dentistry, boosting earlier intervention, prevention and continuity of care.
Read moreMarket comments on behalf of Dat Tong Senior Financial Markets Strategist at Exness
Read moreLetter from the SSAC Chair to the Minister for Social Security and Disability about the Government’s Right to Try policy.
Read moreThousands more children with SEND will get the support that helps them achieve and thrive under new government action to end spiralling independent special school costs.
Read moreGovernment announces a record £73.4 million in funding in 2026 to 2027 for protective security at Jewish, Muslim, and other faith sites.
Read moreToday's markets analysis on behalf of Abdelaziz Albogdady Market Research & Fintech Strategy Manager at FXEM '
Read moreWet weather is set to continue for another month. High tides and strong winds may also bring tidal flood risk in some places during this period.
Read more